This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2015 May 28;372(22):2127-35.

doi: 10.1056/NEJMra1405427.

Latent Mycobacterium tuberculosis infection

Haileyesus Getahun, Alberto Matteelli, Richard E Chaisson, Mario Raviglione

PMID: 26017823
DOI: 10.1056/NEJMra1405427

Review

Latent Mycobacterium tuberculosis infection

Haileyesus Getahun et al. N Engl J Med. 2015.

. 2015 May 28;372(22):2127-35.

doi: 10.1056/NEJMra1405427.

Authors

Haileyesus Getahun, Alberto Matteelli, Richard E Chaisson, Mario Raviglione

PMID: 26017823
DOI: 10.1056/NEJMra1405427

No abstract available

PubMed Disclaimer

Comment in

Latent Mycobacterium tuberculosis Infection.
Getahun H, Chaisson RE, Raviglione M. Getahun H, et al. N Engl J Med. 2015 Sep 17;373(12):1179-80. doi: 10.1056/NEJMc1508223. N Engl J Med. 2015. PMID: 26376149 No abstract available.
Latent Mycobacterium tuberculosis Infection.
Jones JG, King TC. Jones JG, et al. N Engl J Med. 2015 Sep 17;373(12):1178. doi: 10.1056/NEJMc1508223. N Engl J Med. 2015. PMID: 26376150 No abstract available.
Latent Mycobacterium tuberculosis Infection.
Ogbuagu O, Ogbuagu A. Ogbuagu O, et al. N Engl J Med. 2015 Sep 17;373(12):1178. doi: 10.1056/NEJMc1508223. N Engl J Med. 2015. PMID: 26376151 No abstract available.
Latent Mycobacterium tuberculosis Infection.
Tam JK. Tam JK. N Engl J Med. 2015 Sep 17;373(12):1178-9. doi: 10.1056/NEJMc1508223. N Engl J Med. 2015. PMID: 26376152 No abstract available.
Latent Mycobacterium tuberculosis Infection.
Flood J, Scott J, Belknap R. Flood J, et al. N Engl J Med. 2015 Sep 17;373(12):1179. doi: 10.1056/NEJMc1508223. N Engl J Med. 2015. PMID: 26376153 No abstract available.

Similar articles

Tolerability of rifampin monotherapy for latent tuberculosis infection in children.
Daskalaki I, Byun J, Dogbey MC, Tolbert-Warren C, Watson BM. Daskalaki I, et al. Pediatr Infect Dis J. 2011 Nov;30(11):1014-5. doi: 10.1097/INF.0b013e31823234c9. Pediatr Infect Dis J. 2011. PMID: 21997666 No abstract available.
Treatment of latent tuberculosis infection.
Parekh MJ, Schluger NW. Parekh MJ, et al. Ther Adv Respir Dis. 2013 Dec;7(6):351-6. doi: 10.1177/1753465813503028. Epub 2013 Sep 20. Ther Adv Respir Dis. 2013. PMID: 24056289 Review.
Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
Chen YM, Liao TL, Chen HH, Chen DY. Chen YM, et al. Ann Rheum Dis. 2018 Nov;77(11):1688-1689. doi: 10.1136/annrheumdis-2018-213097. Epub 2018 Apr 19. Ann Rheum Dis. 2018. PMID: 29674320 No abstract available.
3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review.
Assefa Y, Assefa Y, Woldeyohannes S, Hamada Y, Getahun H. Assefa Y, et al. Eur Respir J. 2018 Jul 11;52(1):1800395. doi: 10.1183/13993003.00395-2018. Print 2018 Jul. Eur Respir J. 2018. PMID: 29748305 Free PMC article.
Treatment of latent tuberculosis infection in HIV: shorter or longer?
Person AK, Sterling TR. Person AK, et al. Curr HIV/AIDS Rep. 2012 Sep;9(3):259-66. doi: 10.1007/s11904-012-0120-1. Curr HIV/AIDS Rep. 2012. PMID: 22581360 Free PMC article. Review.

See all similar articles

Cited by

Alterations in purine and pyrimidine metabolism associated with latent tuberculosis infection: insights from gut microbiome and metabolomics analyses.
Yang B, Guo X, Shi C, Liu G, Qin X, Chen S, Gan L, Liang D, Shao K, Xu R, Zhong J, Mo Y, Li H, Luo D. Yang B, et al. mSystems. 2024 Nov 19;9(11):e0081224. doi: 10.1128/msystems.00812-24. Epub 2024 Oct 22. mSystems. 2024. PMID: 39436103 Free PMC article.
Intestinal Helminth Infections and Their Association with QuantiFERON-TB Gold Plus Test Performance in an Endemic Setting, Northwest Ethiopia.
Zenebe Y, Abebe M, Munshea A, Yismaw G, Zewde M, Alemayehu M, Lang R, Habtamu M. Zenebe Y, et al. Infect Drug Resist. 2024 Oct 17;17:4487-4500. doi: 10.2147/IDR.S476492. eCollection 2024. Infect Drug Resist. 2024. PMID: 39435458 Free PMC article.
Neutrophil-to-lymphocyte ratio and its association with latent tuberculosis infection and all-cause mortality in the US adult population: a cohort study from NHANES 2011-2012.
Huang Y, Ao T, Zhen P, Hu M. Huang Y, et al. Front Nutr. 2024 Oct 3;11:1467824. doi: 10.3389/fnut.2024.1467824. eCollection 2024. Front Nutr. 2024. PMID: 39421611 Free PMC article.
Changes in immune status of circulating NK cells in patients with latent tuberculosis infection.
Qin S, Chen R, Li M, Lv J, Zhang F, Ren Y, Lin X. Qin S, et al. Cent Eur J Immunol. 2024;49(2):105-112. doi: 10.5114/ceji.2024.142104. Epub 2024 Aug 12. Cent Eur J Immunol. 2024. PMID: 39381552 Free PMC article.
Community-Wide Active Case Finding for Tuberculosis: Time to Use the Evidence We Have.
Coleman M, Lowbridge C, du Cros P, Marais BJ. Coleman M, et al. Trop Med Infect Dis. 2024 Sep 14;9(9):214. doi: 10.3390/tropicalmed9090214. Trop Med Infect Dis. 2024. PMID: 39330903 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

P30 AI094189/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- H1 Connect
- The Lens - Patent Citations Database